1 / 96

Supraesophageal manifestations of GERD

Supraesophageal manifestations of GERD. Symptoms and signs. Symptoms and signs of LPR. Hoarseness 71% Chronic cough 51% Globus pharyngeus 47% Heart burn/regurgitation 43%

iram
Download Presentation

Supraesophageal manifestations of GERD

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Supraesophageal manifestations of GERD

  2. Symptoms and signs Symptoms and signs of LPR • Hoarseness 71% • Chronic cough 51% • Globus pharyngeus 47% • Heart burn/regurgitation 43% • Chronic throat clearing 42% • Difficulty swallowing 35% Cummings(III) ch.126 Gastroesophageal reflux disease P2426

  3. Treatment of Chronic Throat Symptoms with PPIs Should Be Preceded by pH MonitringAm J Gastroenterol 2006;101:6-11 Chronic Throat Symptoms pH Monitoring Empiric treatment with PPIs

  4. PRO:Empiric treatment with PPIs is not appropriate without testing • PPIs are not innocent drugs • Side effects: Headache, diarrhea, constipation, flatulence, abdominal pain, dry mouth. • Less common: anaphylactic shock, Stevens-Johnson syn., pancreatitis, nephritis, toxic epidermal necrolysis. • Predispose treated individuals to pneumonia

  5. PPIs are not innocent drugs • PPIs interfere with neutrophil function by increasing intracellular calcium leading to immunoedeficiency. • In hospitalized patients more CD enteritis. • Mask and delay the diagnosis of esophageal AdenoCa.

  6. PPIs are not innocent drugs • Rebound and hypersecretion after PPIs withdrawal. • Hypergastrinemia • Increased parietal cell mass • Increase ECL cells activity • Rebound might last more than 2 months ( Fossmark et al. )

  7. A successful empirical trial with PPIs does not necessarily confirm the diagnosis of reflux • Meta-analysis by Numans et al: • Sensitivity – 78% • Specificity -54% • Predictive value in LPR should be even lower

  8. PPIs are overused • Placebo effect in LPR is high • Steward et al: • Rabeprazole bid + lifestyle modification 53% response • Vs. Placebo bid + lifestyle modification 50% response Noordzij et al: placebo response of 50% PPI trial in LPR has the predictive value of a coin flip We are creating PPI addicts

  9. Ambulatory pH testing complemented by laryngoscopy • Dual-probe pH testing is the gold standard for LPR • The proximal pH sensor is placed 1cm above the UES in the hypopharyngs • Proximal esophageal acid exposure can not be relied upon to diagnose extraesophageal disease!!!

  10. Ambulatory pH testing • Merati et al. Meta-analysis of 790 extraesophageal pH reports in 16 studies for LPR • Hypopharyngeal pH study does appear to be able to discriminate LPR patients from normal. • Sensitivity of 80%

  11. Laryngoscopy as adjunct test • Laryngoscopy alone cannot be relied upon to make the diagnosis of LPR • Tobacco, environmental pollutants, infections, excessive voice use and allergy can all cause laryngeal inflammation. • Combination of laryngoscopy and dual-probe pH testing should be considered the gold standard in the diagnosis of LPR

  12. Treatment with PPIs should not preceded with pH monitoring in suspected LPR • Prolonged pH monitoring is considered the gold standard in the diagnosis of GERD However • pH monitoring is not likely to help in the diagnosis or treatment of LPR

  13. The important questions: • Does the presence of esophageal acid reflux suggest a casual association between throat symptoms and GERD? • Does the absence of abnormal acid exposure in the esophagus or even in the hypopharyngs suggest lack of such an association? • Should the pH test be performed on or off therapy and does it matter? NO!!!

  14. pH monitoring • The overall pre-therapy prevalence of an abnormal pH test us 53% • The prevalence of excessive distal, proximal and hypopharyngeal acid exposure is 42%, 44% and 38% • No established casual relationship • Number and duration of hypopharyngeal reflux events are similar between controls and LPR patients ( Bilgen et al)

  15. pH testing is a poor predictor of response to therapy • 28/39 patients with posterior laryngitis were found to have abnormal pharyngeal reflux • However, both groups had improvement in symptoms and laryngeal findings with PPIs. (Ulualp et al)

  16. The dichotomy in the literature regarding pH monitoring is a result of: • Probe positioning • Lack of consensus regarding duration and amount of reflux to denote abnormal acid reflux • Poor sensitivity of pH monitoring: 70%, 55% and 40% for distal, proximal and hypopharyngeal probes. • Intermittent nature of reflux events

  17. pH testing in patients under treatment • Was not found to be clinically helpful • Among 115 pts with extraesophageal symptoms while on BID therapy only 2% had abnormal acid exposure. • Impedance studies did not reveal a significant role for non-acid reflux.

  18. Posterior laryngitis

  19. Specificity of laryngoscopy • The laryngeal signs are nonspecific. • In a study o 105 healthy subjects without any symptoms, the majority had abnormal laryngeal findings. • 91/105 (87%) had at least one abnormal finding • 3 abnormal findings have been identified: • Posterior cricoid awall erythema • Vocal cord erythema and edema • Arytenoid medial wall erythema and edema

  20. The role of empiric therapy • Aggressive acid suppression would identify those whose laryngeal signs and symptoms are related to GERD • An overall response rate of 50-70% could be expected. • The lack of response among the remaining patients is most likely related to an overlap between GERD and other causes • The suggestion that PPI therapy is not safe even for a short time period is not based on any solid data.

  21. Medical antireflux treatment of reflux laryngitis: placebo-controlled studies Symptoms Laryngoscopy

  22. תודה רבה

  23. אפידמיולוגיה של תופעות על וושטיות ב-GERD • בנבדקים עם צרבת קלה • ב- 80% נמצאה לפחות תופעה על-ושטית אחת • בנבדקים ללא צרבת • ב-49% נמצאו תופעות על ושטיות במחקר VA על 101,366 נבדקים ב-17% מהנבדקים עם אזופגיטיס היו תופעות על- ושטיות Lock GR et al. Gastroenterology. 1997

  24. Prevalence of extra-oesophageal manifestations in GERD: an analysis based on the ProGERD Study. • 6215 נבדקים עם GERD • ס"ה ב-32.8% תופעות ע"ו • עם אזופגיטיס- 34.9% • ללא אזופגיטיס – 30.5% % Aliment PharmacolTher. 2003Jaspersen D et al

  25. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. (2200 individuals) % Lock GR et al. Gastroenterology. 1997

  26. Introduction Comparision of the GERD Symptoms of the Typical Esophagitis Patient, the “Atypical” Otolaryngology Patient, and Pediatric Patient. Symptoms • Heartburn • Regurgitation • Dysphagia • Cough • Pulmonary infection • Hoarseness • Throat irritation (soreness, clearing) Typical (%) 83 23 40 47 16 12 3 Atypical (%) 20 - 12 26 - 44 87 Pediatric (%) 16 68 30 - 36 - - Koufman JA, Laryngoscope 1991

  27. Introduction Comparision of History, Laryngeal Examination, and Diagnostic Testing in Otolaryngology Patient With Cervical Symptoms(n=63) or Esophagitis(n=36), and in Controls(n=10) A. Symptoms • Heartburn and/or regurgitation • Hoarseness, dysphagia, globus, throat clearing and cough B. Laryngeal Examination • Normal • Erythema • Contact ulcer or granulation C. Diagnostic Studies • Upper esophageal sphincter pressure (mmHg) • Positive standard acid reflux test • Positive Bernstein acid perfusion test • Abnormal esophageal manometry • Esophageal dysmotility • Abnormal esophageal acid clearance Otolaryngology Pt. Esophagitis Pt. 6% 100% 50% 25% 25% 144±121 68% 5% 10% 60% 78% 89% 0% 100% 0% 0% 71±40 100% 89% 8% 10% 80% Koufman JA, Laryngoscope 1991

More Related